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Background.—A case report is a narrative that describes, for medical, scientific, or educational purposes, a medical
problem experienced by one or more patients. Case reports written without guidance from reporting standards are insufficiently
rigorous to guide clinical practice or to inform clinical study design.
Objective.—Develop, disseminate, and implement systematic reporting guidelines for case reports.
Methods.—We used a three-phase consensus process consisting of (1) pre-meeting literature review and interviews to
generate items for the reporting guidelines, (2) a face-to-face consensus meeting to draft the reporting guidelines, and (3)
post-meeting feedback, review, and pilot testing, followed by finalization of the case report guidelines.
Results.—This consensus process involved 27 participants and resulted in a 13-item checklist—a reporting guideline for
case reports. The primary items of the checklist are title, key words, abstract, introduction, patient information, clinical findings,
timeline, diagnostic assessment, therapeutic interventions, follow-up and outcomes, discussion, patient perspective, and
informed consent.
Conclusions.—We believe the implementation of the CARE (CAse REport) guidelines by medical journals will improve
the completeness and transparency of published case reports and that the systematic aggregation of information from case
reports will inform clinical study design, provide early signals of effectiveness and harms, and improve healthcare delivery.
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A case report is a detailed narrative that
describes, for medical, scientific, or educational pur-
poses, a medical problem experienced by one or
several patients.
Case reports present clinical observations cus-
tomarily collected in health-care delivery settings.
They have proved helpful in the identification of
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adverse and beneficial effects, the recognition of new
diseases, unusual forms of common diseases, and the
presentation of rare diseases.1 For example, our
understanding of the relationship between thalido-
mide and congenital abnormalities2 and the use of
propranolol for the treatment of infantile hemangio-
mas began with case reports.3 Case reports may gen-
erate hypotheses for future clinical studies, prove
useful in the evaluation of global convergences of
systems-oriented approaches, and guide the individu-
alization and personalization of treatments in clinical
practice.4,5 Furthermore, case reports offer a structure
for case-based learning in health-care education and
may facilitate the comparison of health-care educa-
tion and delivery across cultures.
Case reports are common and account for a
growing number of articles in medical journals;6
however, their quality is uneven.7,8 For example, one
study evaluated 1316 case reports from 4 peer-
reviewed emergency-medicine journals and found that
more than half failed to provide information related to
the primary treatment that would have increased
transparency and replication.9 Written without the
benefit of reporting guidelines, case reports often are
insufficiently rigorous to be aggregated for data analy-
sis, inform research design, or guide clinical practice.7,9
Reporting guidelines exist for a variety of study
designs including randomized controlled trials (Consoli-
dated Standards of Reporting Trials, or CONSORT),10
observational studies (Strengthening the Reporting of
Observational studies in Epidemiology, or STROBE),11
and systematic reviews and meta-analyses (Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses, or PRISMA).12 Empirical evidence suggests
that a journal’s adoption of the CONSORT statement
as a guide to authors is associatedwith an increase in the
completeness of published randomized trials.13 Guide-
lines have been developed for adverse event case
reports;14 however, general reporting guidelines for case
reports do not exist. Our primary objective was to
develop reporting guidelines for case reports through a
consensus-based process.
METHODS
Research Design.—We followed the Guidance for
Developers of Health Research Reporting Guide-
lines15 and developed a three-phase consensus
process.16 This consisted of (1) a premeeting literature
review followed by interviews to generate items for a
case report checklist, (2) a face-to-face consensus
meeting for drafting a reporting guideline, and (3)
postmeeting feedback and pilot testing followed by
finalization of the case report guidelines.
Participants.—We contacted 28 individuals who
fulfilled at least one of four criteria:17-19 (1) publica-
tion of articles related to case reports; (2) publication
of a manual, handbook, or method guidelines related
to case reports; (3) publication of a systematic review
of methods or reporting related to case reports; and
(4) publication of other reporting guidelines for clini-
cal research.
Consensus Process.—Phase 1: Four of the authors,
the steering committee (JG, GK, DM, and DR),
searched the literature for publications on the role of
case reports, recommendations for their publication,
and surveys on reporting quality.A letter was sent to
28 potential participants explaining the purpose of
the meeting, details of the consensus technique, and
requesting their participation in generating specific
recommendations for case reporting. Twenty-seven
people agreed to participate and were scheduled for a
telephone interview and sent a selection of key
articles on case reports. During the telephone inter-
view, participants were asked (1) what information
was required to be included in case-reporting guide-
lines, (2) the rationale for their suggestions, and (3)
for references that supported their reasoning.
Three of the authors (JG, GK, and DR) grouped
the recommendations from the literature search and
interviews by theme together with their rationale, ref-
erences, and operational definitions. No quantitative
scoring was done.
Phase 2: The face-to-face consensus meeting at
the University of Michigan in Ann Arbor (October
2012) included 18 participants from Phase 1, 1
research assistant and 2 student observers. The
meeting began with a review of the blinded recom-
mendations elicited during the Phase 1 interviews, in
whole group and in small group sessions. On the
second day, open discussion of each potential item
continued, during which clarifications, opinions, justi-
fications, operational definitions, and new ideas were
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expressed. By the end of the second day, the group
had agreed upon a set of preliminary reporting
recommendations.
Phase 3: The draft checklist was refined by the
steering committee and sent for two rounds of review
to the complete group (Phase 1 and 2 participants).
The finalized reporting guidelines incorporated the
feedback from the entire CARE group.
RESULTS
The CAse REport (CARE) guidelines checklist
is structured to correspond with key components of a
case report and capture useful clinical information
(including “meaningful use” information mandated
by some insurance plans).
The checklist begins with a statement that
describes the narrative of a case report. The meeting
CARE group felt that a case report should tell a story
using prose that has a consistent style across all sec-
tions, including the rationale for any conclusions and
take-away messages.
We recommend a timeline (item 7) in the form of
a table or figure that gives the specific dates and times
of important components of the case. This might
include family and past medical history, genetic infor-
mation, current symptoms, diagnostic test results,
interventions, and events that occurred during follow
up. The timeline should show how the key events of
the case unfolded.
We created separate checklist items for diagnos-
tic assessments (item 8) and therapeutic interventions
(item 9) with the recognition that both items often
will be relevant in a case report.
The group discussed at length whether to include
the patient’s perspective on his or her experience. In
the end, we advocated for patient-reported outcomes
and experiences whenever possible (item 12). There
was also discussion about the need for guidelines for
patient-reported outcomes of their care. In a similar
vein, a recent extension of the CONSORT statement
was published for patient-reported outcomes in ran-
domized trials; CONSORT-PRO.20
Finally, we included an item on informed consent
(item 13). We believe that authors have an ethical
duty to obtain informed consent from the patient to
publish patient information in a case report. Consent
becomes informed when the patient or a relative
reads the case report and approves its contents. If the
patient cannot give consent and attempts to find a
relative to give proxy consent have failed, the authors
should seek permission to publish from an institu-
tional committee. There may be other circumstances
where an ethics committee or Institutional Review
Board (IRB) approval may be necessary. The CARE
guidelines are shown in the table.
DISCUSSION
This 13-item checklist provides a framework to
satisfy the need for completeness and transparency
for published case reports. We attempted to strike a
balance between adequate detail and the concise
writing that is one of the appealing characteristics of
a case report. Our consensus process resulted in a set
of essential items for authors to consider when sub-
mitting a case report for publication.
While case reports have long been an important
source of new ideas and information in medicine,21 it
appears that case reports are likely to begin to play a
role in the discovery of what works and for whom.
BioMed Central launched the Journal of Medical
Case Reports in 200722 and a Cases Database in 2012
with more than 11,000 published case reports from
50 medical journals. In 6 months, it has grown to
more than 26,000 case reports from 212 medical jour-
nals.23 The CARE guidelines checklist is part of a
growing effort to improve the reporting of case
reports.
There is substantial empirical evidence that
reporting guidelines improve the completeness of
published scientific reports (eg, see references Turner
et al. [2012], Hopewell et al [2008]. and Hopewell
et al. [2012]13,24,25). A recent Cochrane review exa-
mining the influence of journal endorsement of the
CONSORT statement on reporting included 53 pub-
lications assessing 16,604 randomized controlled
trials and found that CONSORT-endorsing journals
consistently have better overall reporting.13 However,
the potential impact of the CONSORT statement and
related reporting guidelines has not been fully real-
ized. A study examining the instructions to peer
reviewers of 116 health research journals found that
only 41 (35%) provided online instructions to peer
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reviewers. Of those, only 19 (46%) mentioned or
referred to reporting guidelines as a useful resource.26
In response, the authors provide several recommen-
dations for editors to improve the peer review of
submitted manuscripts, suggesting that journals have
a responsibility to support peer reviewers.26
The developers of reporting guidelines have a
responsibility to plan a dissemination and implemen-
tation strategy that supports guidelines utilization.15
Our efforts have several components:
1. The CARE guidelines will be presented at inter-
national conferences and workshops including the
Peer Review and Biomedical Publication Con-
gress in Chicago on September 10, 2013.
2. This article will be published simultaneously in
multiple medical journals and outreach to the 212
journals depositing case reports into the BioMed
Central Case Report Database.
3. We will develop a more detailed explanation and
elaboration article to outline the rationale for each
item and include empirical evidence and examples
of good reporting from published case reports.
4. The CARE guidelines are being pilot tested, and
preliminary results support the guidelines as cur-
rently written (personal communication with
HelmutKiene,ErikaOberg,BillManahan).Guide-
lines extensions for specialties are being developed.
5. The CARE guidelines and related documents will
be available on a dedicated website (http://www
.CARE-statement.org), the EQUATOR Network
website (http://www.equator-network.org), and
translated into multiple languages.
6. Authors, journal editors, peer reviewers, and the
wider medical community are encouraged to use
the CARE checklist and provide feedback that can
be incorporated into regular updates of the CARE
guidelines.
7. We will conduct and support research into the
impact of the CARE guidelines on the reporting of
case reports.
LIMITATIONS
The CARE guidelines and their development
have several possible limitations. First, these guide-
lines were developed through a consensus method
and thus represent the opinions of the participants.
However, consensus was easily reached during our
meeting, we referred to the empirical evidence where
available, and we received feedback from a wide
selection of individuals, beyond those involved in our
consensus meeting. Second, we recognize that causal-
ity determinations are a challenge for case reports
even when following reporting guidelines.27,28 The
CARE guidelines emphasize information quality
independent of causality assessments. Different spe-
cialties, practitioners, and patients are likely to
require extensions of the CARE guidelines with spe-
cialty specific information. We welcome discussions
with groups interested in using the CARE guidelines
as the basis for their specific reporting needs.
Though not mentioned in our guidelines, medical
journals often require authors to address three issues:
(1) potential competing interests, (2) de-identification
of patient-related data, and (3) ethics committee or
IRB approval if obtained or necessary.
CONCLUSIONS
Anticipating a long future for case reports,we have
provided guidance in the form of reporting standards
for use by health-care stakeholders around the world.
The growth of case reports in an era in which clinical
trials and systematic reviews dominate the tables of
content of medical journals indicates that case reports
have value, particularly with the increasing importance
of individualized care. Unlike randomized controlled
trials, case reports are individual reports related to the
care of individual patients where the sample size is one.
When systematically collected and combined into
larger datasets, they can be analyzed, enhancing the
early discovery of effectiveness and harms.
We anticipate that the analysis of systematically
aggregated information from patient encounters
(now mandated by some insurance plans) will
provide scalable, data-driven insights into what works
for which patients in real time, facilitating compari-
sons across medical systems and cultures. Practitio-
ners will soon be able to provide – and in some cases,
they are required to provide – patients with informa-
tion from their encounters. This will transform how
we think about “evidence” and revolutionize its cre-
ation, diffusion, and use – opening new opportunity
1544 November/December 2013
landscapes. When it becomes clear how new data
contribute to evidence, the stewardship needed to
produce high-quality data will be more rewarding and
our attitude toward “observation” will shift. The
CARE guidelines provide a framework to satisfy the
need for precision, completeness, and transparency.
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